Body composition and mortality in chronic obstructive pulmonary disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 1 of the 47 sources its claims cite were checked for support.
Overview
CoChat Summary
TL;DR
In 412 patients with moderate-to-severe COPD, fat-free mass index independently predicted all-cause mortality, whereas fat mass index did not. Low fat-free mass categories (cachexia and muscle atrophy) had worse survival than no impairment, supporting body-composition assessment as a systemic marker in COPD staging.
Key findings
- During a maximum follow-up of 5 y (mean 48 ± 20 mo), 46% of patients (n = 189) died.
- After adjustment for age, sex, FEV₁, IVC, PaCO₂, and PaO₂, fat-free mass index was an independent predictor of mortality (RR: 0.90; 95% CI: 0.84, 0.96; P = 0.003), but fat mass index was not (RR: 1.02; 95% CI: 0.95, 1.09; P = 0.680).
- Median survival was significantly worse in cachexia (26 mo; 95% CI: 21, 31 mo) and muscle atrophy (24 mo; 95% CI: 15, 33 mo) than in semistarvation (36 mo; 95% CI: 28, 44 mo) or no impairment (47 mo; 95% CI: 37, 57 mo) (P < 0.001).
- Cachexia was significantly more prevalent in GOLD stage IV than in GOLD stages II and III (P = 0.001); by SMI criteria, 51% of the total population was at moderate and 31% at high risk of physical disability.
Methods
- Cohort study of 412 clinically stable COPD patients (GOLD stages II–IV; FEV₁ 36 ± 14% of predicted, range 19–70%) screened for admission to a clinical pulmonary rehabilitation program between 1 January 1988 and 30 December 1991; mortality was assessed on 31 January 1993, with follow-up of 2–5 y or until death.
- Body composition was assessed by single-frequency bioelectrical impedance (50 Hz); fat-free mass was calculated with disease-specific equations, fat mass as body weight minus fat-free mass, and FFMI, FMI, and SMI were calculated and compared with reference values. Patients were stratified into cachexia, semistarvation, muscle atrophy, or no impairment by BMI and FFMI cutoffs.
- Main analysis used Kaplan-Meier survival curves, log-rank tests, and Cox proportional hazards models, unadjusted and adjusted for age, sex, disease severity (FEV₁, IVC, PaO₂, PaCO₂), and GOLD classification; P < 0.05 was considered significant.
Limitations
- Stated in the paper: the study population was skewed toward more males and more severe GOLD stages III and IV, and the semistarvation and muscle atrophy categories were relatively small.
- Stated in the paper: smoking status was not objectively verified (e.g., by cotinine measurements), and because smoking was not associated with mortality in these subjects, the reported models excluded smoking.
- Evident from the text: body composition was measured only at baseline, so the sequence of body-composition changes could not be established; emphysema severity was not adjusted for despite being discussed as potentially relevant; and the cohort was selected from rehabilitation screening in the southern Netherlands, which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 27 Not checked · 36 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“These studies all indicate that BIA may be a useful clinical screening instrument for characterization of the tissue-depletion pattern in chronic lung disease.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
What the sources say
- Not checked yetcites [12] Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000;89:465-71. source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [19] Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skel- etal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159:413-21. source
Checked before — its earlier verdict is held back until a new check runs.
- Could not verifycites [20] Gosker HR, Engelen MP, van Mameren H, et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002;76:113-9. sourceExperimental — accuracy not yet measured
Our copy of Gosker et al. (2002) only uses BIA as one of two ways to determine fat-free mass (Methods, 'Assessment of body composition': single-frequency 50 kHz BIA with the disease-specific equation of Schols et al, ref 13) and reports that FFM_BIA correlated with total mean fiber cross-sectional area in the COPD patients (Results/'3-5' passage and Figure 3, r = 0.87, P < 0.001). No passage in our copy evaluates or states that BIA is a useful clinical screening instrument, nor does it use the notion of a 'tissue-depletion pattern' or generalize beyond its 15 stable COPD patients versus 15 controls (Study population). Searched: 'bioelectrical impedance analysis useful clinical screening instrument tissue depletion chronic lung disease', 'FFM BIA validity comparison DXA', 'screening instrument tissue depletion pattern chronic lung disease', 'discussion BIA fat-free mass muscle mass loss wasting clinical implications' — none returned a statement on BIA's screening utility. The validating comparison of BIA with deuterium dilution is credited elsewhere in the reference list (Schols et al. 1991, ref 13), but our copy does not attribute the screening-instrument conclusion to it, so this is not misattribution on our evidence. (LLM, conf=0.62)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not checked yet
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cachexia was significantly (P ҃ 0.001) more prevalent in GOLD stage IV than in GOLD stages II and III.”
- Also stated in: § Abstract · plain
“Semistarvation and muscle atrophy were equally distributed among disease stages, but the highest prevalence of cachexia was seen in GOLD stage IV.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an associationn = 412- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
None of the sources cited for this claim have been checked yet.
In the paper
“In line with that study, male patients in the current study were at higher risk of physical disability than were female patients.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Univariate analysis showed that low BMI, FFMI, and FMI were significantly associated with increased mortality risk (Table 3).”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Forty-six percent of the patients (n ҃ 189) died during a maximum follow-up of 5 y.”
- Also stated in: § 6 x Ȁ SD (all such values). · plain
“The mean duration of follow-up was 48 Ȁ 20 mo, during which time 46% of the patients died.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > Abstract
plainn = 189- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 6 x Ȁ SD (all such values). · plain
32 more claims
Create a free account to see all 63 claims and to verify the 42 references still open.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 13
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.23”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.68, 2.24; NS”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“Mean FFMI in categories 2 and 4 was within median range (50th percentile) except for male patients in category 2, whose values were below the 10th percentile.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“4: No impairment (n ҃ 55) | 59 | 17.6 Ȁ 2.2 | 90th”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“physical disability risk was clearly lower in categories 3 and 4”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“significantly (P 0.001) more patients were at moderate to high risk of disability in the cachexia and muscle atrophy categories (ie, 1 and 3) than in semistarvation and noimpairment categories (ie, 2 and 4)”
Citations
Cites
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015 · cited 1×
“On the basis of numerous reports showing an association between BMI and mortality risk in COPD, Celli at al (26) recently proposed that clinical staging for COPD should be based not only on spirometry and resting arterial blood gases, eg, the recent GOLD criteria, but also on BMI, exercise capacity, and dyspnea score.”
BackgroundAssessment of fat-free mass using bioelectrical impedance measurements of the human body
Lukaski, H., Johnson, P., Bolonchuk, W., & Lykken, G. (1985) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/41.4.810 · Cited by 1,896 · cited 1×
“Bioelectrical impedance analysis (BIA) is an easy, safe, noninvasive, and convenient method of measuring the lean and fat body compartments (11).”
MethodEstimation of skeletal muscle mass by bioelectrical impedance analysis
Janssen, I., Heymsfield, S. B., Baumgartner, R. N., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.465 · Cited by 1,482
Skeletal Muscle Cutpoints Associated with Elevated Physical Disability Risk in Older Men and Women
Janssen, I. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh058 · Cited by 1,190
Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease
SCHOLS, A. M. W. J., SLANGEN, J., VOLOVICS, L., & WOUTERS, E. F. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9705017 · Cited by 1,085
Self-citationPrognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease
LANDBO, C., PRESCOTT, E., LANGE, P., VESTBO, J., & ALMDAL, T. P. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.6.9902115 · Cited by 1,033
Marquis, K., Debigaré, R., Lacasse, Y., LeBlanc, P., Jobin, J., Carrier, G., & Maltais, F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107031 · Cited by 844
Schols, A. M. W. J., Soeters, P. B., Dingemans, A. M. C., Mostert, R., Frantzen, P. J., & Wouters, E. F. M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1151 · Cited by 725
Self-citationFat-free mass index and fat mass index percentiles in Caucasians aged 18–98 y
Schutz, Y., Kyle, U., & Pichard, C. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802037 · Cited by 670
Schols, A. M., Soeters, P. B., Mostert, R., Pluymers, R. J., & Wouters, E. F. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.4.7551381 · Cited by 463
Self-citation
Cited by
Items 401–500 of 898
Differences in the Outcome of Patients with COPD according to Body Mass Index
Ji, Z., de Miguel‐Díez, J., Castro-Riera, C. R., Bellón, J. M., González, V. G., Girón-Matute, W. I., Jiménez‐García, R., López‐de‐Andrés, A., Alvarez, V. M., Puente‐Maestu, L., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030710 · Cited by 21
Karanikas, I., Karayiannis, D., Karachaliou, A., Papanikolaou, A., Chourdakis, M., & Kakavas, S. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.09.035 · Cited by 21
Berton, D. C., da Silveira, L. E., da Costa, C. C., de Souza, R. M., Winter, C. D., & Teixeira, P. J. Z. (2013) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2013.02.005 · Cited by 21
Obesity and Functioning Among Individuals with Chronic Obstructive Pulmonary Disease (COPD)
Katz, P., Iribarren, C., Sánchez, G., & Blanc, P. D. (2015) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2015.1087991 · Cited by 21
Caram, L., Ferrari, R., Bertani, A. L., Garcia, T., Mesquita, C. B., Knaut, C., Tanni, S. É., & Godoy, I. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164290 · Cited by 21
Muscle wasting in the presence of disease, why is it so variable?
Kemp, P. R., Griffiths, M., & Polkey, M. I. (2018) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12489 · Cited by 23
Nutritional Management Guidelines for Sarcopenia and Frailty 2025
Kuzuya, M., Kanno, Y., Arai, H., Nishiguchi, S., Iijima, K., Umegaki, H., Satake, S., Satô, S., Shinmura, K., Sugimoto, K., et al. (2025) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.70275 · Cited by 20
Oyama, Y., Tatsumi, H., Takikawa, H., Taniguchi, N., & Masuda, Y. (2024) · Nutrients · doi:10.3390/nu16050739 · Cited by 20
Lu, J., Wang, Q., Xie, L., Zhang, Q., & Sun, S. (2017) · Tobacco Induced Diseases · doi:10.1186/s12971-017-0148-5 · Cited by 20
Coordinated regulation of skeletal muscle mass and metabolic plasticity during recovery from disuse
Kneppers, A. E. M., Leermakers, P. A., Pansters, N. A. M., Backx, E. M. P., Gosker, H. R., van Loon, L. J. C., Schols, A. M. W. J., LANGEN, R. C. J., & Verdijk, L. B. (2018) · The FASEB Journal · doi:10.1096/fj.201701403rrr · Cited by 20
Self-citationGökdeniz, T., Kalaycıoğlu, E., Boyacı, F., Aykan, A. Ç., Gürsoy, M. O., Hatem, E., Börekçi, A., Karabağ, Y., & Altun, S. (2014) · Respiration · doi:10.1159/000365222 · Cited by 20
Mineo, D., Ambrogi, V., Lauriola, V., Pompeo, E., & Mineo, T. C. (2010) · European Respiratory Journal · doi:10.1183/09031936.00142309 · Cited by 20
Mesquita, C. B., Knaut, C., Caram, L., Ferrari, R., Bazan, S. G. Z., Godoy, I., & Tanni, S. É. (2018) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37562017000000019 · Cited by 20
Thibault, R., Gallic, E. L., Picard-Kossovsky, M., Darmaun, D., & Chambellan, A. (2010) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2010.06.013 · Cited by 20
Pulmonary rehabilitation--from guidelines to practice.
Postolache, P. A., & Cojocaru, D.-C. (2013) · The Medical-Surgical Journal · Cited by 20
Muscle Wasting in Chronic Obstructive Pulmonary Disease
Wouters, E. F. �. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2510003 · Cited by 20
Self-citationBuchmann, N., Norman, K., Steinhagen‐Thiessen, E., Demuth, I., & Eckardt, R. (2015) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-015-0958-0 · Cited by 19
Systemic Inflammation in Chronic Obstructive Pulmonary Disease: May Diet Play a Therapeutic Role?
Toraldo, D. M., Nuccio, F. D., & Scoditti, E. (2011) · Journal of Allergy & Therapy · doi:10.4172/2155-6121.s2-005 · Cited by 19
Should all patients with COPD be exercise trained?
Ribeiro, F. A., Thériault, M., Debigaré, R., & Maltais, F. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01124.2012 · Cited by 19
Ju, C., & Chen, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084167 · Cited by 21
Malnutrition and obesity in COPD
Rutten, E. P. A., Wouters, E. F. �., & Franssen, F. M. E. (2013) · European Respiratory Society eBooks · doi:10.1183/1025448x.10039912 · Cited by 19
Self-citationHoang, V., Li, G. W., Kao, C. C., Dronavalli, G., & Parulekar, A. D. (2016) · Clinical Transplantation · doi:10.1111/ctr.12897 · Cited by 19
Schneider, L. P., Sartori, L. G., Machado, F. V. C., Pola, D. C. D., Rugila, D. F., Hirata, R. P., Bertoche, M. P., Camillo, C. A., Hernandes, N. A., Furlanetto, K. C., et al. (2020) · Brazilian Journal of Physical Therapy · doi:10.1016/j.bjpt.2020.07.005 · Cited by 19
Systematic review and meta-analysis of lean mass and mortality: Rationale and study description
Cheung, C.-L., Lee, G. K.-Y., Au, P. C.-M., Li, G. H.-Y., Chan, M., Li, H.-L., Cheung, B. M.-Y., Wong, I. C.-K., Lee, V. H.-F., Mok, J., et al. (2021) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2021.01.001 · Cited by 18
The Nutritional Status of Chronic Obstructive Pulmonary Disease Exacerbators
Silvestre, C. R., Domingues, T. D., Mateus, L., Cavaco, M. J., Nunes, A. F. S., Cordeiro, R. J. P. D. M., Santos, T. S., Falcão, T., & Domingos, A. C. (2022) · Canadian Respiratory Journal · doi:10.1155/2022/3101486 · Cited by 18
Differential impacts between fat mass index and fat-free mass index on patients with COPD
Shimada, T., Chubachi, S., Otake, S., Sakurai, K., Sasaki, M., Iijima, H., Tanabe, N., Tanimura, K., Shimizu, K., Shirahata, T., et al. (2023) · Respiratory Medicine · doi:10.1016/j.rmed.2023.107346 · Cited by 18
Ferrari, R., Tanni, S. É., Faganello, M. M., Caram, L., Lucheta, P. A., & Godoy, I. (2010) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2010007500150 · Cited by 18
Somatotypes trajectories during adulthood and their association with COPD phenotypes
Divo, M. J., Marín‐Oto, M., Macario, C. C., López, C. C., de-Torres, J. P., Marín, J. M., Hersh, C. P., Ezponda, A., Maguire, C. A., Pinto-Plata, V., et al. (2020) · ERJ Open Research · doi:10.1183/23120541.00122-2020 · Cited by 18
Vikjord, S. A. A., Brumpton, B. M., Mai, X., Romundstad, S., Langhammer, A., & Vanfleteren, L. E. G. W. (2022) · Respirology · doi:10.1111/resp.14222 · Cited by 18
Samaras, N., Samaras, D., Chambellan, A., Pichard, C., & Thibault, R. (2014) · BioMed Research International · doi:10.1155/2014/248420 · Cited by 18
Barker, B., McKenna, S., Mistry, V., Pancholi, M., Patel, H., Haldar, K., Barer, M. R., STEINER, M. C., Brightling, C. E., Bafadhel, M., et al. (2014) · International Journal of COPD · doi:10.2147/copd.s63568 · Cited by 18
Lee, I. S., Leem, A. Y., Lee, S. H., Rhee, Y., Ha, Y., & Kim, Y. S. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.127 · Cited by 18
Doña, E., Olveira, C., Palenque, F. J., Porras, N., Dorado, A., Martín‐Valero, R., Godoy, A., Espíldora, F., Contreras, V., & Olveira, G. (2018) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.01.013 · Cited by 18
Fonseca, F. R., Karloh, M., de Araújo, C. L. P., dos Reis, C. M., & Mayer, A. F. (2018) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37562017000000121 · Cited by 18
Reassessing the BODE score as a criterion for listing COPD patients for lung transplantation
Pirard, L., & Marchand, É. (2018) · International Journal of COPD · doi:10.2147/copd.s182483 · Cited by 18
Knaut, C., Mesquita, C. B., Dourado, V. Z., Godoy, I., & Tanni, S. É. (2020) · International Journal of Inflammation · doi:10.1155/2020/6492720 · Cited by 18
Bernardes, S., Silva, F. M., da Costa, C. C., de Souza, R. M., & Teixeira, P. J. Z. (2021) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2214 · Cited by 18
Causes of Death and Prediction of Mortality in COPD
Solanes, I., & Casán, P. (2010) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(10)70082-3 · Cited by 18
Bernardes, S., Teixeira, P. J. Z., & Silva, F. M. (2022) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2390 · Cited by 17
The muscle hypothesis of shortness of breath in patients with cachexia
Anker, S. D., Khan, M. S., Khan, L. A., Rosano, G. M. C., Volterrani, M., Lainščak, M., Ponikowski, P. P., & Coats, A. J. S. (2024) · Global Cardiology · doi:10.4081/cardio.2024.57 · Cited by 17
Nutritional Support of Chronic Obstructive Pulmonary Disease
Simon, P., Török, É., Szalontai, K., Kari, B., Neuperger, P., Zavala, N., Kanizsai, I., Puskás, L. G., Török, S., & Szebeni, G. J. (2025) · Nutrients · doi:10.3390/nu17071149 · Cited by 19
Tsutsumi, A., Chubachi, S., Irie, H., Sasaki, M., Yamada, Y., Sugiura, H., Jinzaki, M., Nakamura, H., Asano, K., Betsuyaku, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87724-8 · Cited by 17
Metabolomics of Respiratory Diseases
Moitra, S., Bandyopadhyay, A., & Lacy, P. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2022_614 · Cited by 17
Effets d’un programme de réhabilitation respiratoire selon la sévérité de la BPCO
Beaumont, M., Reychler, G., Ber-Moy, C. L., & Péran, L. (2011) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2010.09.034 · Cited by 17
Sood, A., Petersen, H. V., Meek, P., & Tesfaigzi, Y. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201306-1060oc · Cited by 17
Predictors of Functional Performance in Community‐Dwelling People with COPD
Wall, M. P. (2007) · Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.2007.00172.x · Cited by 17
Sato, M., Inai, K., Asagai, S., Harada, G., Shimada, E., & Sugiyama, H. (2020) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.04.011 · Cited by 16
Yang, J., Cao, R. Y., Li, Q. X., & Zhu, F. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_15 · Cited by 16
Gale, N., Albarrati, A., Munnery, M. M., McDonnell, B. J., Benson, V. S., Tal‐Singer, R., Cockcroft, J. R., & Shale, D. J. (2019) · Medicina · doi:10.3390/medicina55040089 · Cited by 16
Dietary Behaviour and Nutrition in Patients with COPD Treated with Long-Term Oxygen Therapy
Mękal, D., Czerw, A. I., & Deptała, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312793 · Cited by 16
Yang, L., Zhu, Y., Huang, J., Jin, J., & Zhang, X. (2019) · Medical Science Monitor · doi:10.12659/msm.914783 · Cited by 16
Ashby, D. R., Choi, P., & Bloom, S. R. (2008) · Proceedings of The Nutrition Society · doi:10.1017/s0029665108007143 · Cited by 16
Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!
Jouneau, S., Léderlin, M., Vernhet, L., & Thibault, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.00418-2019 · Cited by 16
Altınöz, H., Adıgüzel, N., Saltürk, C., Güngör, G., Moçin, Ö. Y., Takır, H. B., Kargın, F., Balcı, M. K., Dikensoy, Ö., & Karakurt, Z. (2016) · International Journal of COPD · doi:10.2147/copd.s108813 · Cited by 15
Nutrition implications of intrinsic restrictive lung disease
Rinaldi, S., Balsillie, C., Truchon, C., Al-Mubarak, A., Mura, M., & Madill, J. (2022) · Nutrition in Clinical Practice · doi:10.1002/ncp.10849 · Cited by 15
Inoue, T., Takeuchi, I., Iida, Y., Takahashi, K., Nagano, F., Miyazaki, S., Shirado, K., Yoshimura, Y., Momosaki, R., Maeda, K., et al. (2022) · JMA Journal · doi:10.31662/jmaj.2021-0202 · Cited by 15
Cell-Free DNA Maps Tissue Injury and Correlates with Disease Severity in Lung Transplant Candidates
Balasubramanian, S., Richert, M. E., Kong, H., Fu, S., Jang, M. K., Andargie, T. E., Keller, M. B., Alnababteh, M. H., Park, W., Apalara, Z., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202306-1064oc · Cited by 15
Inflammatory biomarkers in chronic obstructive pulmonary disease
Викторович, Л. И., & Baranova, I. I. (2012) · PULMONOLOGIYA · doi:10.18093/0869-0189-2012-0-2-108-117 · Cited by 15
Enteral Nutrition in the Chronic Obstructive Pulmonary Disease (COPD) Patient
DeBellis, H. F., & Fetterman, J. W. (2012) · Journal of Pharmacy Practice · doi:10.1177/0897190012460827 · Cited by 15
Rehabilitation and supportive therapy in elderly patients with Chronic Obstructive Pulmonary Disease
Crisafulli, E., Morandi, A., Olivini, A., Malerba, M., & Clini, E. M. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.01.003 · Cited by 15
Marino, D. M., Marrara, K. T., Arcuri, J. F., Candolo, C., Jamami, M., & Lorenzo, V. A. P. D. (2014) · Brazilian Journal of Physical Therapy · doi:10.1590/s1413-35552012005000146 · Cited by 15
Brinchault, G., Diot, P., Dixmier, A., Goupil, F., Guillais, P., Gut‐Gobert, C., Leroyer, C., Marchand-Adam, S., Meurice, J.-C., Morel, H., et al. (2015) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2015.09.009 · Cited by 15
Travassos, A., Rodrigues, A., Furlanetto, K. C., Donária, L., Bisca, G. W., Nellessen, A. G., Pitta, F. D. O., & Hernandes, N. A. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.105 · Cited by 15
Caron, M., Debigaré, R., Dekhuijzen, P. N. R., & Maltais, F. (2011) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2011.04.015 · Cited by 16
Cano, N., Pichard, C., Court‐Fortune, I., Costes, F., Cynober, L., Gérard-Boncompain, M., Molano, L. C., Cuvelier, A., Laaban, J.-P., Melchior, J., et al. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.08.011 · Cited by 15
Gyldenløve, M., Sørensen, J. A., Fage, S. W., Meteran, H., Skov, L., Zachariae, C. O. C., Knop, F. K., Nielsen, M., & Egeberg, A. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2024.02.036 · Cited by 14
Association between muscular atrophy and mortality risk in patients with COPD: a systematic review
Li, W., Wu, Y., Yang, X., Zhu, J., Feng, M., Deng, R., Yang, C., & Sun, C. (2024) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666241304626 · Cited by 14
Leptin and Insulin in COPD: Unveiling the Metabolic-Inflammatory Axis—A Narrative Review
Catană, O. M., Nemeş, A. F., Cioboată, R., Toma, C., Mitroi, D. M., Călăraşu, C., & Streba, C. T. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082611 · Cited by 14
Lakhdar, R., Drost, E., MacNee, W., Bastos, R., & Rabinovich, R. (2017) · Respiratory Research · doi:10.1186/s12931-017-0525-x · Cited by 15
Extending the value of routine lung screening CT with quantitative body composition assessment
Xu, K., Gao, R., Tang, Y., Deppen, S. A., Sandler, K. L., Kammer, M. N., Antic, S., Maldonado, F., Huo, Y., Khan, M. S., et al. (2022) · SPIE Medical Imaging: Image Processing · doi:10.1117/12.2611784 · Cited by 14
Diago, C. A. A., Martín-Audera, P., Calvo, J. A., Lavín, B. A., Guerra-Ruiz, A. R., Muñoz, P., Berja, A., Casanova, C., & García‐Unzueta, M. T. (2022) · Scientific Reports · doi:10.1038/s41598-022-21757-5 · Cited by 14
Fu, C., & Yang, H. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1159949 · Cited by 14
Macario, C. C., Tajes, J. P. D. T., & Palmero, M. Á. M. (2009) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(09)72861-3 · Cited by 14
Berstad, P. M., Randby, A., Ekeland, G. S., Ulveland, H., Omland, T., & Almendingen, K. (2011) · British Journal Of Nutrition · doi:10.1017/s000711451100417x · Cited by 14
COPD: osteoporosis and sarcopenia
Majid, H., Kanbar-Agha, F., & Sharafkhaneh, A. (2016) · COPD Research and Practice · doi:10.1186/s40749-016-0019-0 · Cited by 14
Casaburi, R. H., Nakata, J., Bistrong, L., Torres, E., Rambod, M., & Pórszász, J. (2015) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.3.1.2015.0128 · Cited by 14
Odencrants, S., & Theander, K. (2012) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2012.04184.x · Cited by 14
Farooqi, N., Sandström, T., Slinde, F., Håglin, L., & Carlsson, M. (2015) · International Journal of COPD · doi:10.2147/copd.s80616 · Cited by 14
Músculos respiratorios, tolerancia al ejercicio y entrenamiento muscular en la EPOC
Barreiro, E., Gea, J., & Marín‐Corral, J. (2007) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(07)71181-x · Cited by 15
El papel de las exacerbaciones en la historia natural de la EPOC
Soler‐Cataluña, J. J. (2007) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(07)71028-1 · Cited by 14
Associations between BODE index and systemic inflammatory biomarkers in COPD
Gaki, Ε., Kontogianni, K., Papaioannou, A. Ι., Bakakos, P., Gourgoulianis, K. I., Κostikas, Κ., Alchanatis, M., Papiris, S. A., & Loukides, S. (2011) · European Respiratory Journal · doi:10.1183/13993003/erj.38.suppl_55.p3515 · Cited by 14
Zou, R. H., Nouraie, M. S., Karoleski, C. M., Zhang, Y., Sciurba, F. C., Forman, D. E., & Bon, J. M. (2023) · Respiratory Research · doi:10.1186/s12931-023-02521-3 · Cited by 13
SEPAR and SEEN Consensus Document on Nutritional Assessment and Management in Patients with COPD
de Miguel‐Díez, J., Llanos, J. P. S., Gonçálves, J. M. F., Lesmes, I. B., Torres‐Castro, R., Golpe, R., Hernández, N. C. I., Diago, C. A. A., Delgado, Y. G., Ojembarrena, A. A., et al. (2025) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2025.08.009 · Cited by 13
Incidence and predictors of COPD mortality in Uganda: A 2-year prospective cohort study
Alupo, P., Wosu, A. C., Mahofa, A., Mugenyi, L., Semakula, D., Katagira, W., & Kirenga, B. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246850 · Cited by 13
Pathak, P., Panday, S. B., & Ahn, J. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.11.027 · Cited by 13
Reference equations for quadriceps strength, endurance and power: a multicentre study
Tanguay, S., Saey, D., Marklund, S., Nyberg, A., Géphine, S., Frykholm, E., Brandt, J. D., Burtin, C., & Maltais, F. (2023) · ERJ Open Research · doi:10.1183/23120541.00313-2023 · Cited by 13
Theeuwes, W. F., Pansters, N. A. M., Gosker, H. R., Schols, A. M. W. J., Verhees, K. J. P., de Theije, C. C., van Gorp, R. H., KELDERS, M. C. J. M., Ronda, O. A. H. O., Haegens, A., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165740 · Cited by 13
Self-citationPandolfi, P., Zanasi, A., Musti, M. A., Stivanello, E., Pisani, L., Angelini, S., Maffei, F., Hrelia, S., Angeloni, C., Zenesini, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135116 · Cited by 13
Farooqi, N., Nordström, L., Lundgren, R., Sandström, T., & Håglin, L. (2010) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2010.06.005 · Cited by 13
Factors that influence dietary intake in adults with stable chronic obstructive pulmonary disease
Shalit, N., Tierney, A. C., Holland, A. E., Miller, B., Norris, N., & King, S. (2016) · Nutrition & Dietetics · doi:10.1111/1747-0080.12266 · Cited by 13
Assessment of Aerobic Exercise Adverse Effects during COPD Exacerbation Hospitalization
Knaut, C., Mesquita, C. B., Caram, L., Ferrari, R., Dourado, V. Z., Godoy, I., & Tanni, S. É. (2017) · Canadian Respiratory Journal · doi:10.1155/2017/5937908 · Cited by 13
Nutritional status and dietary intake of outpatients with chronic obstructive pulmonary disease
Humphreys, K. J., Cross, G., Frith, P. A., & Cafarella, P. (2008) · Nutrition & Dietetics · doi:10.1111/j.1747-0080.2008.00235.x · Cited by 13
Nutritional rehabilitation: from pulmonary cachexia to sarcoPD
Schols, A. M. W. J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00011209 · Cited by 13
Self-citationZani, R. A. M., Yusof, H. A., Azizan, N. A., Ali, I. A. H., Ismail, S., & Shariff, N. M. (2025) · BMC Public Health · doi:10.1186/s12889-025-22819-9 · Cited by 12
van Isselt, E. F. V. D., Groenewegen-Sipkema, K. H., van Eijk, M., Chavannes, N. H., & Achterberg, W. P. (2018) · Chronic Respiratory Disease · doi:10.1177/1479972318809456 · Cited by 12
Two functional variants at 6p21.1 were associated with lean mass
Pei, Y., Hu, W., Yang, X., Wei, X., Feng, G.-J., Zhang, H., Shen, H., Tian, Q., Deng, H., & Zhang, L. (2019) · Skeletal Muscle · doi:10.1186/s13395-019-0212-3 · Cited by 12
Effect of Pulmonary Rehabilitation on Erector Spinae Muscles in Individuals With COPD
Higashimoto, Y., Shiraishi, M., Sugiya, R., Mizusawa, H., Nishiyama, O., Ryo, Y., Iwanaga, T., Chiba, Y., Tohda, Y., & Fukuda, K. (2021) · Respiratory Care · doi:10.4187/respcare.08678 · Cited by 12
Wouters, E. F. �. (2021) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2021.725534 · Cited by 12
Self-citationJenkins, A. R., Gaynor-Sodeifi, K., Lewthwaite, H., Triandafilou, J., Belo, L. F., Oliveira, M. F., & Jensen, D. (2023) · ERJ Open Research · doi:10.1183/23120541.00102-2023 · Cited by 12
Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers
Caram, L., Ferrari, R., Nogueira, D. L., Oliveira, M. R., Francisqueti‐Ferron, F. V., Tanni, S. É., Corrêa, C. R., & Godoy, I. (2017) · International Journal of COPD · doi:10.2147/copd.s138558 · Cited by 12
Metadata
- Authors
- Schols, A. M., Broekhuizen, R., Weling-Scheepers, C. A., & Wouters, E. F.
- Affiliations
- Maastricht University (NL)
- Corresponding author
- Schols, Annemie MWJ
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 82
- Issue
- 1
- Pages
- 53-59
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2150051820
- Cited by
- 902
- References
- 35
- Citations by year
- 2026: 24 · 2025: 32 · 2024: 34 · 2023: 44 · 2022: 41 · 2021: 47 · 2020: 49 · 2019: 49 · 2018: 45 · 2017: 45 · 2016: 60 · 2015: 57 · 2014: 61 · 2013: 55 · 2012: 37
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 6456 d)
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- chronic obstructive pulmonary disease, body composition, mortality, fat-free mass index, fat mass index, skeletal muscle index, cachexia, muscle atrophy, semistarvation, disease severity
- MeSH terms
- Body Composition, Body Weight, Cachexia, Female, Humans, Male, Middle Aged, Reference Values, Respiratory Function Tests, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.